Edwards Lifesciences (EW) Short-Term Debt issuances (2010 - 2013)

Edwards Lifesciences has reported Short-Term Debt issuances for 4 years, with the latest figure at $372.9 million in Q3 2013.

• For the quarter ending Q3 2013, Short-Term Debt issuances rose 1036.89% year-over-year to $372.9 million; the trailing twelve-month figure through Sep 2013 stood at $874.2 million (up 238.18% YoY), and the FY2012 full-year result was $407.0 million, down 22.64% from the prior year.
• Short-Term Debt issuances for Q3 2013 stood at $372.9 million, up from $168.4 million in the prior quarter.
• The five-year high for Short-Term Debt issuances was $372.9 million in Q3 2013, with the low at $20.6 million in Q4 2011.
• Average Short-Term Debt issuances over 4 years is $126.2 million, with a median of $104.5 million recorded in 2010.
• Year-over-year, Short-Term Debt issuances plunged 89.25% in 2012 and jumped 1036.89% in 2013.
• Tracing EW's Short-Term Debt issuances over 4 years: stood at $37.6 million in 2010, then plunged by 45.21% to $20.6 million in 2011, then soared by 720.87% to $169.1 million in 2012, then jumped by 120.52% to $372.9 million in 2013.
• The last three Short-Term Debt issuances figures came in at $372.9 million (Q3 2013), $168.4 million (Q2 2013), and $163.8 million (Q1 2013), per Business Quant data.

Peer Comparison